Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 2:14:1359148.
doi: 10.3389/fonc.2024.1359148. eCollection 2024.

Apriori prediction of chemotherapy response in locally advanced breast cancer patients using CT imaging and deep learning: transformer versus transfer learning

Affiliations

Apriori prediction of chemotherapy response in locally advanced breast cancer patients using CT imaging and deep learning: transformer versus transfer learning

Amir Moslemi et al. Front Oncol. .

Abstract

Objective: Neoadjuvant chemotherapy (NAC) is a key element of treatment for locally advanced breast cancer (LABC). Predicting the response to NAC for patients with Locally Advanced Breast Cancer (LABC) before treatment initiation could be beneficial to optimize therapy, ensuring the administration of effective treatments. The objective of the work here was to develop a predictive model to predict tumor response to NAC for LABC using deep learning networks and computed tomography (CT).

Materials and methods: Several deep learning approaches were investigated including ViT transformer and VGG16, VGG19, ResNet-50, Res-Net-101, Res-Net-152, InceptionV3 and Xception transfer learning networks. These deep learning networks were applied on CT images to assess the response to NAC. Performance was evaluated based on balanced_accuracy, accuracy, sensitivity and specificity classification metrics. A ViT transformer was applied to utilize the attention mechanism in order to increase the weight of important part image which leads to better discrimination between classes.

Results: Amongst the 117 LABC patients studied, 82 (70%) had clinical-pathological response and 35 (30%) had no response to NAC. The ViT transformer obtained the best performance range (accuracy = 71 ± 3% to accuracy = 77 ± 4%, specificity = 86 ± 6% to specificity = 76 ± 3%, sensitivity = 56 ± 4% to sensitivity = 52 ± 4%, and balanced_accuracy=69 ± 3% to balanced_accuracy=69 ± 3%) depending on the split ratio of train-data and test-data. Xception network obtained the second best results (accuracy = 72 ± 4% to accuracy = 65 ± 4, specificity = 81 ± 6% to specificity = 73 ± 3%, sensitivity = 55 ± 4% to sensitivity = 52 ± 5%, and balanced_accuracy = 66 ± 5% to balanced_accuracy = 60 ± 4%). The worst results were obtained using VGG-16 transfer learning network.

Conclusion: Deep learning networks in conjunction with CT imaging are able to predict the tumor response to NAC for patients with LABC prior to start. A ViT transformer could obtain the best performance, which demonstrated the importance of attention mechanism.

Keywords: LABC; ViT transformer; deep learning; neoadjuvant chemotherapy; response prediction and CT imaging.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The diagram illustrates a deep learning methodology for forecasting the response to NAC in LABC patients. The lower segment illustrates the application of transfer learning utilizing pre-trained CNNs, while the upper segment illustrates training from the ground up using the Vision Transformer (ViT) approach. In the ViT architecture, images are segmented into patches and converted into a sequential format, akin to the sequence of words in Natural Language Processing (NLP). The positional encoding ensures that each patch’s location retains crucial information. The core component is the transformer encoder, which includes patch embedding transformation, multi-head attention, and MLP.
Figure 2
Figure 2
CT images of tumors of patients with LABC who did not respond to treatment (left) and tumors of patients with LABC who did respond to treatment (right).

Similar articles

Cited by

References

    1. Giordano SH. Update on locally advanced breast cancer. oncologist. (2003) 8:521–30. doi: 10.1634/theoncologist.8-6-521 - DOI - PubMed
    1. Tryfonidis K, Senkus E, Cardoso MJ, Cardoso F. Management of locally advanced breast cancer—perspectives and future directions. Nat Rev Clin Oncol. (2015) 12:147–62. doi: 10.1038/nrclinonc.2015.13 - DOI - PubMed
    1. Goetz MP, Gradishar WJ, Anderson BO, Abraham J, Aft R, Allison KH, et al. . NCCN guidelines insights: breast cancer, Version 3.2018: featured updates to the NCCN guidelines. J Natl Compr Cancer Network. (2019) 17:118–26. - PubMed
    1. Senkus E, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rutgers E, et al. . Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. (2015) 26:v8–v30. doi: 10.1093/annonc/mdv298 - DOI - PubMed
    1. Rajan R, Poniecka A, Smith TL, Yang Y, Frye D, Pusztai L, et al. . Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response. Cancer: Interdiscip Int J Am Cancer Soc. (2004) 100:1365–73. doi: 10.1002/cncr.20134 - DOI - PubMed

LinkOut - more resources